HDM-induced rhinitis
Conditions
Sponsors
TORII PHARMACEUTICAL CO., LTD.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) HDM-specific IgE antibodies >= Class 3 (2) Positive on HDM nasal provocation test (3) Medical history of treatment for HDM-induced rhinitis (4) Moderate or severe symptoms of HDM-induced rhinitis
Exclusion criteria
Exclusion criteria: (1) Specific IgE antibodies >= Class 5 any of the following: cedar, cypress, alder, cocksfoot, ragweed, mugwort, Japanese hop, cockroach, Candida, Aspergillus, Alternaria, dog hair, or cat hair (2) Allergic rhinitis symptoms with class 2 to 4 in the specific IgE antibodies any of the following: cocksfoot, ragweed, mugwort, Japanese hop, cockroach, Candida, Aspergillus, Alternaria, dog hair, or cat hair (3) Class 2 to 4 in the specific IgE antibody to dog hair or cat hair, and no rhinitis symptoms, but constantly exposed to the relevant animal (e.g., pet parenting at home, working at a pet shop) (4) Patients who received immunotherapy with HDM allergen-containing products (e.g., house dust) for at least 1 month during 5 years before the first day of observation. (5) Patients who are on immunotherapy other than HDM allergen-containing products on the first day of observation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy, Dose dependency, Safety | — |
Outcome results
None listed